Combining nicotine patches and bupropion in smoking cessation therapy;Asociacion de bupropion y parches de nicotina como terapia para dejar de fumar

Archivos de Bronconeumologia

Volumn 36, Issue 7, 2000, Pages 377-380

  Sampablo Lauro, I ^a   Lores, L ^a   Coll, F ^b   Rebasa, P ^a  

^a Hospital de Sant Boi   (Spain)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

Bupropion; Nicotine patch; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ADDICTION; ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; SMOKING CESSATION; TREATMENT OUTCOME; CLINICAL TRIAL; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED;

ADMINISTRATION, CUTANEOUS; BUPROPION; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING CESSATION;

EID: 0034217801     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30137-x     Document Type: Article

References (26)

1. o (C.D.C.) 8416, 1990.
2. U.S. Department of Health and Human Services. The Health consequences of involuntary smoking. A report of the Surgeon General U.S. Department of Health and Human Services, Public Health Service. C.D.C. D.H.H.S. Publicación n.o (C.D.C.) 87-8.398, 1986.
3. To J. Tabaco y cáncer: de la asociación epidemiológica a la evidencia molecular. Med Clin (Barc) 1999; 112: 589-594.
4. Estudio de los estilos de vida de la población adulta española. Ministerio de Sanidad y Consumo. Madrid: Dirección General de Salud Pública, 1992.
5. Departament de Sanitat i Seguretat Social (DSSS). Enquesta de Salut de Catalunya. Servei Català de Salut. Barcelona: SCS, DSSS, 1995.
6. Lores L, Monsó E, Rosell A, Badorrey I, Sampablo Lauro I. ¿Nos mienten los enfermos controlados en un dispensario de neumología respecto a su hábito tabáquico? Arch Bronconeumol 1999; 35: 219-222.
7. Giovino GA, Shelton DM, Schooley MW. Trend in cigarette smoking cessation in the United States. Tobacco Control 1993; 2 (Supl): 3-16.
8. Smoking and Health. A physician responsibility. A statement of the Joint Committee on Smoking and Health. Eur Respir J 1995; 8: 808-811.
9. Benowitz NL. Pharmacological aspects of cigarettes smoking and nicotine addiction. N Engl J Med 1988; 319: 1318-1330.
10. Hurt RD, Sachs D, Glover E, Offord KP et al. A comparison of sustained release bupropion and placebo for smoking cessation. N Engl J Med 1997: 337; 1195-1202.
11. Prochazcka J, Diclemente C. Stages and processes of self change of smoking: toward and integrative model of change. J Consult Clin Psychology 1983; 51: 390-395.
12. Orleans C, George L, Houpt J. Health promotion in primary care: a survey of U.S. family practitioners. Prevent Med 1985; 14: 636-647.
13. Ockene JK. Physician-delivered interventions for smoking cessation: strategies for increasing effectiveness. Prevent Med 1987; 16: 723-737.
14. Jiménez CA, Fagerström KO. Reducción del consumo de tabaco. ¿Una estrategia para dejar de fumar? Arch Bronconeumol 1999; 35: 229-232.
15. Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen A, Forchammer M et al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988; 318: 15-18.
16. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six month results from two multicenter controlled clinical trials. JAMA 1991; 266: 3133-3138.
17. Snyder RF, Davis FO, Henningfield JE. The tobacco withdrawal syndrome. Performance decrements assessed on a computerized test battery. Drug Alcohol Depend 1989; 23: 259-266.
18. Kato S, Wakasa Y, Yanagita T. Relationship between minimum reinforcing doses and injection speed in cocaine and pentobarbital self administration in crabeating monkeys. Pharmacol Biochm Behav 1987; 28: 407-410.
19. Gritz ER. Patterns of puffing in cigarette smokers. Self-administration of abused substances: methods for study (NIDA Research Monograph 20). Rockville, Maryland: National Institute on Drug Abuse, 1978; 221-235.
20. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31: 350-354.
21. Ferry LH, Burchette RJ. Efficacy of bupropion for smoking cessation in non-depressed smokers. J Addict Dis 1994; 13: 249.
22. Jorenby DE, Leischow SJ, Nides M, Rennard S et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691.
23. Tonnesen P, Paoletti P, Gustavsson G, Russell M et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Respir J 1999; 13: 238-246.
24. o 90-3064). Bethesda, 1989.
25. Prochazcka J, Diclemente CC. Stages of change in the modification of problems behaviors. En: Hersen M, Eisler R, Miller P, editores. Progress in behaviors modification. Newbury Park, California:
26. Prochazcka J, Velicer W, Diclemente CC. Predicting change in smoking status for self changers. Addict Behav 1985; 10: 395-406.